UCB to invest £1 billion into UK R&D
December 6, 2018Manufacturing and Production, Research and Development R&D, UCB, UK, brussels, investment, research
The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector …
British researchers sequences 100,000 whole genomes
December 6, 2018Research and Development Matt Hancock, digital, genome, personalised medicnie
British researchers have sequenced 100,000 whole genomes as part of an effort to improve understanding of rare diseases and move …
Bayer to cut 12,000 jobs by 2025
December 6, 2018Business Services, Manufacturing and Production, Sales and Marketing Bayer, Germany, Jobs, manfucaturing, monsanto, production
German pharma giant Bayer is set to cut 12,000 jobs by 2025 as part of a plan to focus on …
Takeda shareholders approve $62bn Shire acquisition
December 6, 2018Business Services Ireland, Japan, M&A, MA, Shire, Takeda, acquisition
Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc. The …
Sanofi announce cull of 670 French jobs
December 6, 2018Business Services, Manufacturing and Production CGT, France, Jobs, Macron, Sanofi, gilet jaunes, yellow jackets
French pharma giant Sanofi has said that it will cut 670 jobs in France over the next two years. The …
Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline
December 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, GSK, Interview, UK, US, digital, senior global director, technology
Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …
Amgen unveils double whammy of data for its investigational cancer immunotherapies at ASH 2018
December 5, 2018Research and Development ASH 2018, Amgen, Cancer, acute myeloid leukaemia, myeloma, pharma
Amgen has presented the first clinical data at the American Society of Hematology (ASH) Annual Meeting 2018 for two investigational …
New diagnostic test can detect any cancer type in minutes with 90% accuracy
December 5, 2018Research and Development Australia, Cancer, pharma
Researchers at the University of Queensland have a test which can rapidly detect the presence of cancer in a patient’s …
UK Government announces first-of-its-kind Vaccines Manufacturing Innovation Centre
December 5, 2018Research and Development UK, pharma, vaccines
Plans for a Vaccines Manufacturing Innovation Centre in the UK have been unveiled by Business Secretary Greg Clark, in a …
Roche’s first-line Tecentriq combo scores accelerated FDA review
December 5, 2018Research and Development ASH 2018, Cancer, Roche, lung cancer, pharma, tecentriq
Roche’s immunotherapy Tecentriq has secured Priority Review from the FDA, the company has announced, in combination with carboplatin and etoposide …
Darzalex “significantly reduces” disease progression and death in multiple myeloma at ASH 2018
December 5, 2018Research and Development ASH 2018, Janssen, darzalex, multiple myeloma, pharma
Janssen has taken the opportunity at the American Society of Hematology (ASH) Annual Meeting 2018 to unveil new Phase 3 …
NICE approves Cimzia but blocks Ilumetri in treatment of psoriasis
December 4, 2018Manufacturing and Production, Sales and Marketing Almirall, Cimzia, Ilumetri, NICE, UCB, UK, pharma, psoriasis
UK drug watchdog NICE has announced two new recommendations relating to medicines for the treatment of psoriasis, approving UCB Pharma’s …
Pfizer’s biosimilar proves non-inferior to rituximab in lymphoma at ASH 2018
December 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASH 2018, Pfizer, haemophilia
Joining the chorus of data presentations at the American Society of Hematology (ASH) Annual Meeting 2018, Pfizer has announced new …
Hemlibra shows “clinically meaningful” bleed control in paediatric haemophilia A patients
December 4, 2018Manufacturing and Production, Research and Development ASH 2018, Hemlibra, Roche, haemophilia, pharma
In another reveal at the American Society of Hematology (ASH) Annual Meeting 2018, Roche unveiled new Phase 3 findings for …
Cancer drug access for NHS patients is slowing, ICR reports
December 4, 2018Manufacturing and Production, Research and Development, Sales and Marketing Cancer, ICR, Institute of Cancer Research, NHS, NICE, UK, pharma
A new report from the Institute of Cancer Research (ICR) has indicated that NHS patients in the UK are suffering …
Roche chooses Veeva Vault PromoMats for digital asset management and content
December 4, 2018Manufacturing and Production, Medical Communications Roche, pharma, veeva
Today, at the 2018 Veeva Commercial & Medical Summit Europe, Roche (SWX:ROG) announced that it would be adopting Veeva Systems …
Insider Interview: The diabetes/mental health connection
December 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Type 1 diabetes, World Diabetes Day, diabetes, feature, mental health, pharma
Michael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey …
Shire’s Takhzyro scores EU approval in rare genetic disorder hereditary angioedema
December 3, 2018Sales and Marketing EU, Europe, Shire, Takhzyro, pharma
Shire has announced that it has secured European approval for its subcutaneous injection Takhzyro (lanadelumab) for the routine prevention of …
Gilead’s CAR-T therapy Yescarta shows two-year response duration in large B-cell lymphoma
December 3, 2018Research and Development, Sales and Marketing ASH 2-18, CAR-T, Cancer, Gilead, Yescarta, leukaemia, pharma
Gilead has gone head to head with Novartis at the American Society of Hematology (ASH) Annual Meeting 2018, meeting the …
GSK to acquire oncology biotech Tesaro for $5.1 billion
December 3, 2018Sales and Marketing GSK, GlaxoSmtihKline, Tesaro, acquisition, oncology, pharma
GlaxoSmithKline is set to acquire US-based oncology biotech Tesaro after both companies signed a definitive agreement with an aggregate cash …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
